Grants and Contributions:

Back to search

Title:

TheraQ automated Neuro-based Mental Health Risk Assessment system.

Agreement Number:

1003139

Agreement Value:

$75,000.00

Agreement Date:

Feb 1, 2023 - Feb 29, 2024

Description:

The purpose of this project is to design, develop, test, and validate an EEG-biomarker based mental health risk assessment system. The system offers clinicians information that can be readily understood in the context of established neurotherapy research literature. Based on this foundation, TheraQ will offer a quantitative mental health risk assessment framework that clinicians can immediately put to use, to prioritize and build training and other interventions that directly help their clients accelerate their recovery.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Toronto, Ontario, CA M5G 0A8

Reference Number:

172-2022-2023-Q4-1003139

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

708762935

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.

Amendment Date

Dec 11, 2023

Recipient's Operating Name:

Divergence Neuro

Recipient's Legal Name:

Divergence Neuro Technologies Inc.

Federal Riding Name:

University--Rosedale

Federal Riding Number:

35110

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

3391

Amendments:

See Amendments